36th International Symposium on ALS/MND

San Diego, USA

Friday 5 December – Sunday 7 December 2025

  • Home
  • About
    • About the event
    • Past Symposia
    • Future dates
    • Sign up for updates
  • Sponsors and Exhibitors
    • Sponsors and Exhibitors
    • Sponsor Recognition Programme
  • Programme
    • Programme
    • Plenary Speakers
  • For Presenters
    • For Presenters
    • For Oral Presenters
    • For Poster Presenters
    • Poster Prize
  • Information
    • Venue
    • Accommodation
    • First Announcement
  • Register
  • Menu
Home » Latest News » Phase 3 clinical trial results – levosimendan

Phase 3 clinical trial results – levosimendan

Posted on by Symposium Admin
Posted in Latest News.

Post navigation

← Virtual Symposium: Through the eyes…
Health and social care retrospective:… →
logo
© 2025 MND Association: Registered in England. Registered Charity no. 294354
  • Contact
  • Sitemap
  • Cookies Policy
  • Privacy Policy
  • Terms and Conditions
  • Sign up for updates

Follow us

  • facebook
  • twitter
  • youtube
  • instagram
© 2022 MND Association: Registered in England. Registered Charity no. 294354
A SiteOrigin Theme